Financial Enhancement »

Protagonist Therapeutics shares owned by Financial Enhancement

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Financial Enhancement from 13F filings

Historical chart of Financial Enhancement investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Financial Enhancement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Financial Enhancement

Quarter filed Position value Share count Share price at filing
2023-03-31 $1.1M 42k 25.40

More positions owned by Financial Enhancement

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Index Shs Fds Msci Eafe Strtgc (QEFA)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Janus Detroit Str Tr Henderson Securi (JSI)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
First Tr Exch Traded Fd Iii Lng/sht Equity (FTLS)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Linde SHS (LIN)
Ishares Tr S&p 100 Etf (OEF)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Visa Com Cl A (V)

View all positions for Financial Enhancement

Top funds holding Protagonist Therapeutics

BVF
Vanguard Group
Point72 Asset Management
Kynam Capital Management
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Dimensional Fund Advisors
683 Capital Management
Candriam Luxembourg S.C.A.
Goldman Sachs Group
Charles Schwab Investment Management
Citadel Advisors
Jpmorgan Chase & Co
Gratus Capital
Perceptive Advisors

View all funds holding Protagonist Therapeutics